| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1055 |
| 1 | DUPILUMAB | 937 |
| 2 | ETANERCEPT | 818 |
| 3 | TIRZEPATIDE | 301 |
| 4 | METHOTREXATE SODIUM | 245 |
| 5 | METHOTREXATE | 236 |
| 6 | EVOLOCUMAB | 226 |
| 7 | PREDNISONE | 161 |
| 8 | ERGOCALCIFEROL | 157 |
| 9 | FOLIC ACID | 124 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 26 | 0.0138 |
| 1 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 32 | 0.0059 |
| 2 | DILUENT | 6 | 0.0058 |
| 3 | ERGOCALCIFEROL | 157 | 0.0053 |
| 4 | DEOXYCHOLIC ACID | 11 | 0.0047 |
| 5 | TALIMOGENE LAHERPAREPVEC | 7 | 0.0044 |
| 6 | RILONACEPT | 5 | 0.0043 |
| 7 | METRELEPTIN | 5 | 0.0040 |
| 8 | FREMANEZUMAB-VFRM | 38 | 0.0032 |
| 9 | IOVERSOL | 12 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 937 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 833 |
| 2 | GLP-1 Receptor Agonist [EPC] | 576 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 320 |
| 4 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 301 |
| 5 | Corticosteroid [EPC] | 278 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 235 |
| 7 | Vitamin C [EPC] | 175 |
| 8 | Vitamin B12 [EPC] | 152 |
| 9 | Vitamin D [EPC] | 148 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 26 | 0.0138 |
| 1 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 2 | Leptin Analog [EPC] | 5 | 0.0040 |
| 3 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 21 | 0.0020 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 937 | 0.0018 |
| 6 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 27 | 0.0016 |
| 8 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 9 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |